Type 2 Diabetes Trial, Recruiting NCT06426277 Sponsor: Beneficência Portuguesa de São Paulo Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06426277
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older (there is no upper age limit)
  • People with a body mass index (BMI) between 18.5 and 34.9 (a measure of body weight relative to height)
  • People who own or have access to at least one electronic device, such as a computer, laptop, tablet, or smartphone
  • People who have access to the internet (any type of connection)
  • People who have not received nutritional counseling in the past 6 months
  • People who have not worked with a personal trainer or physical education professional in the past 6 months
  • People who live within 60 minutes of the research center
  • People who have been diagnosed with prediabetes, confirmed by two blood sugar (HbA1c) test results between 5.7% and 6.4%, taken between 7 and 90 days apart

Who may not be able to join:

  • People who have been diagnosed with diabetes, or who have taken blood sugar-lowering medication within the past three months
  • People with a serious underlying illness that may shorten life expectancy or increase the risk of developing type 2 diabetes
  • People with a diagnosed kidney disease
  • People with a diagnosed lung disease
  • People with a gastrointestinal (digestive) disease
  • People who have had treatment to prevent a second heart attack or stroke (secondary cardiovascular prevention)
  • People with hormonal or gland-related (endocrine) diseases
  • People who have lost more than 10% of their body weight in the past 6 months (except weight loss related to having recently given birth)
  • People with uncontrolled high blood pressure
  • People who have been diagnosed with Polycystic Ovary Syndrome (self-reported)
  • People currently being treated for tuberculosis (except those taking isoniazid as a preventive measure)
  • People with conditions that may severely limit life expectancy or ability to take part in the study
  • People who are pregnant or breastfeeding
  • People with severe psychiatric conditions that, in the opinion of the clinical team, would make it difficult to participate
  • People who drink alcohol excessively, either occasionally or regularly
  • People with a specific type of heart failure (congestive heart failure) rated above Class 2 on a standard medical scale (confirm with trial site)
  • People whose answers to a standard physical activity readiness questionnaire (PAR-Q) indicate they need to see a heart specialist before exercising
  • People who are currently participating, or have participated in the past 6 months, in another clinical trial that could affect this study's results
  • People who are likely to move away from the research center area within the next 3 years
  • People who live in the same household as another participant or team member of this study (the PROVEN-DIA study)
  • People who are unwilling to be randomly assigned to a treatment group or who do not agree to sign the consent form
  • People who regularly take certain medications, including most corticosteroids (except creams, eye drops, or inhalers), cancer treatments, or certain psychiatric medications (confirm with trial site for full medication list)
  • People who took part in the earlier pilot version of this study (NCT05689658)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Angela C Bersch-Ferreira, PhD, Hospital Beneficência Portuguesa de São Paulo

Phone: (55 11) 988295600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beneficência Portuguesa de São Paulo
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
31 December 2029

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Incidence of type 2 diabetes mellitus (T2DM)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov